Calcium Hydroxylapatite Fillers Market Size To Reach $1.6 Billion By 2030

Calcium Hydroxylapatite Fillers Market Growth & Trends

The global calcium hydroxylapatite (CaHA) fillers market is expected to reach USD 1.6 billion by 2030 and it is projected to grow at a CAGR of 13.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is expected to grow due to factors such as growing regulatory approvals for combination dermal fillers, changing aesthetic standards across developed and developing countries, favorable financial accessibility options for patients, and an increasing population of geriatric patients susceptible to facial wrinkles and volume loss.

The industry's growth is driven by the increasing adoption and development of advanced calcium hydroxylapatite (CaHA) fillers. The integration of hyaluronic acid (HA) with calcium hydroxylapatite (CaHA) to aid in patients suffering from facial volume loss aids growth. For instance, HA contributes to immediate volumizing effects, addressing fine lines and wrinkles. In addition, CaHA's collagen-stimulating properties lead to sustaining results, extending the longevity of the treatment.

An increase in strategic initiatives amongst the key players of calcium hydroxylapatite (CaHA) fillers is anticipated to propel growth. For instance, in September 2023, CGBio launched its filler range, FACETEM, in Indonesia. Consequently, in October 2023, CGBio signed an export contract worth 100 million USD with HTDK to expand its CaHA filler offerings in Mainland China. Furthermore, in October 2020, AbbVie Inc. acquired Luminera, a company based in Israel with a portfolio and pipeline of dermal fillers.

 Request a free sample copy or view report summary: Calcium Hydroxylapatite Fillers Market Report

Calcium Hydroxylapatite Fillers Market Report Highlights

• The calcium hydroxylapatite (CaHA) fillers industryin the healthcare market was estimated at USD 648.1 Million in 2023 and is expected to reach USD 1.6 Billion in 2030

• The marketis expected to grow at a compound annual growth rate of 13.8% from 2024 to 2030 to reach USD 1.6 Billion by 2030

• In 2023, North America held the largest share of the market, with a revenue share of 35.2%. The growing geriatric population in the U.S., which is susceptible to skin imperfections or diseases, is expected to increase the demand for filler procedures, thereby significantly contributing to the market growth over the forecast period

• By application, the facial wrinkles and folds segment accounted for the largest revenue share of 51.24% in 2023 driven by the ability of CaHA filler to effectively diminish lines and add volume in areas affected by age-related loss of skin fullness

• By end use, the medspas segment accounted for a dominant revenue share of 51.56% in 2023. Aesthetic filler procedures are primarily performed by medspas owing to low patient downtime and the non-invasive nature of cosmetic surgery

Calcium Hydroxylapatite Fillers Market Segmentation

Grand View Research has segmented the global calcium hydroxylapatite (CaHA) fillers market based on application, end-use, and region:

Calcium Hydroxylapatite Fillers Application Outlook (Revenue, USD Million, 2018 - 2030)

• Facial wrinkles and folds

• Jawline contouring

• Lipoatrophy

• Others

Calcium Hydroxylapatite Fillers End use Outlook (Revenue, USD Million, 2018 - 2030)

• MedSpas

• Cosmetic Surgery Center

• Hospitals

Calcium Hydroxylapatite Fillers Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of key players in the Calcium Hydroxylapatite Fillers Market

• Merz Pharma

• AbbVie Inc.

• CGBio

• Cytophil, Inc.

• DR. Korman.

• Luminera